DSGRMEDIUM SIGNALFINANCIAL10-K

DSGR reported solid operational improvements with meaningfully higher operating income and strong cash generation, though interest expense increased substantially due to higher debt levels.

The company demonstrated strong operational execution with operating income growing notably and operating cash flow expanding meaningfully, indicating improved business performance across their integrated MRO distribution platform. However, the substantial increase in interest expense suggests higher leverage levels that investors should monitor, particularly in a rising rate environment.

Comparing 2026-03-05 vs 2025-03-06View on EDGAR →
FINANCIAL ANALYSIS

DSGR showed strong operational performance with operating income growing notably to $78.3M and operating cash flow expanding meaningfully to $83.8M, reflecting improved business fundamentals. However, interest expense increased substantially to $42.8M, indicating higher debt levels following their strategic acquisitions. The company also increased capital expenditures modestly to $21.0M, suggesting continued investment in growth initiatives.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+76%
$24.3M$42.8M

Interest expense surged 76% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
+53.6%
$13.7M$21.0M

Capital expenditure jumped 53.6% — major investment cycle underway; assess returns on deployment.

Operating Cash Flow
Cash Flow
+48.5%
$56.5M$83.8M

Operating cash flow surged 48.5% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+39.9%
$56.0M$78.3M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

LANGUAGE CHANGES
NEW — 2026-03-05
PRIOR — 2025-03-06
ADDED
As of February 27, 2026, 46,186,293 shares of common stock were outstanding.
and foreign governments; supply chain constraints, inflationary pressure and labor shortages; and foreign currency exchange rate changes.
Through the strategic Mergers (as defined below) completed in 2022, the complementary distribution businesses of Lawson Products, Inc.
( Lawson ), a leader in MRO distribution of C-parts, TestEquity Acquisition, LLC ( TestEquity ), a leader in electronic test and measurement solutions, and 301 HW Opus Holdings, Inc., which conducts business as Gexpro Services ( Gexpro Services ), a leading global supply chain services provider to manufacturing customers were combined under the DSG holding company.
On April 1, 2022, DSG, which at the time already owned Lawson, acquired TestEquity and Gexpro Services, in transactions in which TestEquity and Gexpro Services were merged with and into subsidiaries of DSG, with Lawson, TestEquity and Gexpro Services surviving as wholly-owned subsidiaries of DSG, and in connection with which DSG issued shares of DSG common stock to the former equityholders of TestEquity and Gexpro Services in exchange for their equity interests in TestEquity and Gexpro Services ( the Mergers ).
+7 more — sign up free →
REMOVED
As of February 28, 2025, 46,558,913 shares of common stock were outstanding.
DSG was formed in 2022 through the strategic mergers of Lawson Products, a leader in MRO distribution of C-parts, TestEquity, a leader in electronic test measurement solutions and Gexpro Services, a leading global supply chain services provider to manufacturing customers.
A summary of the mergers is presented in Note 1 Nature of Operations and Basis of Presentation, in Item 8.
DSG serves approximately 200,000 distinct customers in several diverse end markets supported by approximately 4,400 dedicated employees and strong vendor partnerships.
Recent Events 2024 Business Acquisitions On November 18, 2024, DSG acquired the assets of ConRes Test Equipment, ( ConRes TE and the ConRes TE Transaction ).
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →